News UK partners with Eli Lilly on obesity plan The UK has teamed up with Eli Lilly on initiatives, backed with £85 million in funding, to expand access to treatment for obesity.
News Obesity is rising fastest in young adults in England An analysis of around 54m health records in England has revealed rising rates of obesity, particularly among young adults and disadvantaged groups.
Digital Dr Craig Primack: How telehealth closes obesity care gaps What does Hims & Hers aspire to achieve as it enters into new markets? Dr Craig Primack discusses misinformation surrounding obesity and weight loss.
News UK approves Novo Nordisk's Wegovy pill Novo Nordisk's fast-growing Wegovy pill has been approved in the UK for weight loss, its first European market.
News Basketball great Shaq fronts Lilly sleep apnoea campaign Eli Lilly has recruited basketball legend Shaquille O'Neal to promote a sleep apnoea awareness campaign and make the case for treatment with Zepbound.
News ADA: AZ reveals oral GLP-1 data in obesity, diabetes AstraZeneca prepares to move its oral GLP-1 elecoglipron into phase 3 for obesity and diabetes, after reporting encouraging phase 2b data at ADA.
News Despite study bust, Vistagen still hopes to file anxiety dru... Vistagen has chalked up another trial failure for fasedienol, its drug candidate for social anxiety disorder.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
